DIANE ST PIERRE: Open Payments
NPI 1750427068 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 18 payments from 11 companies in 2025. Trend: 2023 $145 · 2024 $366 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $128 |
| Lilly USA, LLC | 3 | $58 |
| Janssen Biotech, Inc. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $47 |
| Karyopharm Therapeutics Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $29 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
| Genmab U.S., Inc. | 1 | $22 |
| SOBI, INC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: VENCLEXTA, VERZENIO, LIBTAYO, XPOVIO, IMBRUVICA, Vanflyta, Asparlas, Epkinly.
Industry payments across TX — which companies pay providers there.
